| Name | Title | Contact Details |
|---|
Skye Bioscience Inc. is a clinical-stage biotechnology company based in San Diego, California. The company focuses on developing innovative therapeutics for metabolic diseases, particularly obesity, by modulating the endocannabinoid system. Skye Bioscience is advancing its lead product, Nimacimab, a monoclonal antibody that targets peripheral CB1 receptors. This treatment aims to provide effective weight loss solutions while minimizing neuropsychiatric side effects associated with previous therapies. Nimacimab is currently in a Phase 2 trial, evaluating its efficacy in weight loss and metabolic health. The company is also exploring combination therapies to enhance treatment outcomes. Skye Bioscience positions Nimacimab as a potential alternative to existing GLP-1-based therapies, targeting patients who need sustainable weight loss with improved safety profiles. The obesity drug market presents significant opportunities, and Skye is actively participating in clinical trials and industry conferences to advance its mission in metabolic health.
JDC Welfare Organization is a charitable, non-profit, and non-governmental organization in Pakistan that is dedicated to disaster management, education, healthcare, and other relief services.
Carnel Inc is a Huntsville, AL-based company in the Business Services sector.
Invetech is a San Diego, CA-based company in the Business Services sector.
Rock Engineered Machinery Co is a Livermore, CA-based company in the Business Services sector.